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ABSTRACT
Objectives: Constipation is a common problem in children. Chronic functional constipation (CFC) has been
a claimed conditions that may increase the risk for urinary tract infections (UTIs). Dysfunctional voiding (DV)
and lower urinary tract dysfunctions (LUTD) with chronic constipation are referred to dysfunctional elimination
syndromes (DES). The aim of the present review is to look at the management of constipation in children with
CFC or DES in reducing the risk of recurrent UTIs. 
Methods: We performed a literature search on electronic databases (Pubmed and Scopus) for relevant clinical
trials investigating the results of one or more treatments for children’s constipation in the term of UTIs
recurrence. 
Results: The search strategy identified 20 valuable clinical trials. The studies are not homogenous but showed
an improvement in UTIs occurrences in children managed for bowel dysfunction. 
Conclusion: In conclusion, children referred to a pediatric nephrologist for UTIs should include an inquiry
bowel habits and those with a positive assessment for bowel dysfunction needs the collaboration with a pediatric
gastroenterologist with a multidisciplinary approach. 
Keywords: Children, constipation, dysfunctional elimination syndromes, dysfunctional voiding, urinary tract
infection
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rinary tract infections (UTIs) are frequent in
children. By seven years of age, 8% of girls and
2% of boys will have had at least one episode of UTI
[1]. Prospective studies using 99mTc-labelled
dimercaptosuccinic acid (DMSA) scintigraphy have
shown that, after a febrile UTI, 30-40% of children
will have renal scarring [2]. Follow-up data has
established that long-term complications of UTIs with
renal scarring include hypertension, proteinuria,
pregnancy-related complications and even end-stage
kidney failure [3]. Many predisposing factors to UTIs
recurrence (vesicoureteral reflux [VUR], bladder and
bowel dysfunction [BBD], and genetic factors) have
described in childhood [4, 5]. Both BBD and VUR are
at high risk of developing recurrent UTIs than children
with isolated VUR or children with isolated BBD [6].
There is still controversy about the role of chronic
functional constipation (CFC) in predisposing children
to UTIs [7]. 
      Constipation is a common problem in children
with a prevalence from 0.7% to 29.6% [8]. According
to the Paris Consensus on Childhood Constipation
Terminology (PACCT) Group, CFC as having at least
two symptoms during the last eight weeks that include
U
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defecation frequency of less than three times, a fecal
incontinence, frequency more than once, passage of
large stools that clog the toilet, a palpable abdominal
or rectal fecal mass, stool withholding and painful
defecation [9]. CFC is chronic constipation without
evidence of pathological conditions [10] and, at
present, the most accepted definitions for CFC are the
Rome III criteria [11]. In particular, sensation of
anorectal blockage, straining during defecation and
infrequent bowel movements are of great accuracy for
the diagnosis of CFC [12]. Constipation may play a
role in function and dysfunction of the urinary tract
[13]. 
      Dysfunctional voiding (DV), that refers to an
intermittent and/or fluctuating uroflow rate due to
involuntary intermittent contractions of the striated
muscle of the external urethral sphincter or pelvic
floor during voiding in normal individuals [14], and
lower urinary tract dysfunctions (LUTD), that refers
to patients with problems of bladder function [14], as
dysfunctional elimination syndromes (DES) [15] with
CFC [16]. DES and CFC increased the risk of UTIs in
children [15, 17]. In agreement, it has observed
recurrent UTIs in 25% of boys and 66% of girls
among 180 patients with CFC [19], and in 62% of girls
among 80 patients with DES [18]. 
      Children with UTIs have more symptoms of
constipation than without [20]. Wan et al. [21]
suggested that up to 90% of children with UTI could
have dysfunctional voiding or constipation habits. 
Although the degree of fecal loading, as seen on a
plain abdominal radiograph, is not synonymous of
constipation, there is a significant association between
the degree of fecal loading and UTIs [22]. Decreased
bladder filling, impression of the bladder wall
provoking overactivity, and pelvic floor dis-
coordination caused by withdrawal manoeuvres as a
response to painful defecation can have an important
clinical meaning [23]. Another hypothesis is that
constipation can figure bacterial stasis with huge
proliferation and translocation of the same bacteria
into genitourinary apparatus. In fact, it has reported a
correlation between intestinal bacterial stasis,
methanogenic intestinal flora and UTIs [24]. 
      The general approach to the child with functional
constipation comprises dietary interventions (high
fibre diet, hydration changes), behavioural change,
regular toilet habits and laxatives to assure that bowel
movements occur at normal intervals with good
evacuation [11]. 
The aim of the present look at to check if management
of constipation in children with CFC or DES reduce
the risk of UTIs recurrence. 
METHODS
      We performed a systematic literature search on
electronic databases (Pubmed and Scopus) for relevant
clinical trials published from January 1985 to June
2018, investigating the results of one or more
treatments for children’s constipation in the term of
the resolution or amelioration of UTIs recurrence. 
To find relevant articles in these electronic databases,
we used the keywords constipation OR dysfunctional
elimination syndrome OR dysfunctional voiding AND
urinary tract infection AND children. 
      Studies were qualified for inclusion if they were
clinical trials (excluding observational studies, letters,
case reports, conference abstracts, studies on animals
and comments), searching for the role of one or more
treatments for constipation in the term of the
resolution or amelioration of UTIs recurrence. 
      First, we screened the list of titles and abstracts
(total number identifies: 321); then we selected
clinical trials and the articles of interest in their
entirety. The strategy identified 20 clinical trials. We
extracted the first author and year of publication, the
number of cases, characteristics of constipation and
treatment, and time of follow-up. We extracted
information on the prevalence of constipation and UTI
before and after the treatment.
RESULTS
Clinical trials
      Twenty clinical trials (Table 1) involving patients
with CFC or DES reported different treatment
regimens for constipation (laxatives, enemas, high-
fibre diet, biofeedback therapy, pelvic floor muscle
exercises, sacral neuromodulation, regular voiding,
pharmacotherapy etc.) [23, 25-43]. 
      Studies that showed a significant reduction of
UTIs related to DV [26-28, 40] or DES [29, 30, 32] or
LUTD [42]. Other studies did not report if the results
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Table 1. Characteristics and analysis of the included clinical trials 
 
Clinical trials n. (M/F) Mean age (range) Main pathology Treatment 
Follow-
up 
n. of patients 
with 
constipation 
before/after 
n. of patients 
with UTI 
before/after 
Chrzan 2008 
[23] 50 (6/44) 
9.6 
(6.5-12) yrs 
CFC, recurrent 
UTIs Colonic washout enemas 6 mos 
50/33 
p = n.a. 
50/20 
p = n.a. 
Kibar 2007 [25] 78 (8/70) 7.20 ± 2.04 (5-14) yrs 
DV, vescico-
ureteral reflux 
Biofeedback, timed 
voiding 6 mos 
9/2 
p = n.a. 
41/8 
p = n.a 
Vesna 2010 [26] 
86 (35/51) 
 
Group A 43 
(15/28) 
Group B 32 
(9/23) 
7.1 ±2.5 
(3-13) yrs DV 
Group A) Standard 
urotherapy, pelvic floor 
exercises 
Group B) conservative 
treatment 
Laxatives; antibiotic 
prophylaxis if UTIs 
recurred in both groups 
1 yr 
Group A 
15/0 
p < 0.001 
Group B 
10/4 
p < 0.05 
Group A 
19/6 
p < 0.0001 
Group B 
15/9 
p < 0.05 
Vesna 2011 [27] 
86 (35/51) 
 
Group A 43 
(15/28) 
Group B 32 
(9/23) 
Group A 
7.5±2.5 yrs 
Group B 
6.7±2.5 yrs 
DV 
Group A) diaphragmatic 
breathing, pelvic floor 
muscles retraining plus 
group B treatment, 
Group B) regular voiding, 
hydration, posture, 
laxatives; antibiotic 
prophylaxis if UTIs 
recurred 
1 yr 
Group A 
15/0 
p < 0.0001 
Group B 
10/4 
p < 0.05 
Group A 
19/6 
p < 0.001 
Group B 
15/9 
p < 0.05 
Zivkovic 2012 
[28] 43 (15/28) 
7.5±2.5 
(5-13) yrs DV 
Pharmacotherapy (11 
anticholinergics, 11 
desmopressin, 15 
antibiotic prophylaxis); 
constipation treatment 
(education and laxatives); 
diaphragmatic breathing 
exercises; pelvic floor 
muscle exercises 
1 yr 15/0 p < 0.0001 
19/6 
p < 0.0001 
Kajbafzadeh 
2011 [29] 
80 (18/62) 
 
Group A 40 
(8/32) 
Group B 40 
(10/30) 
Group A 
8.5±2.7 yrs 
Group B 
9±2.3 yrs 
DES 
Group A) animated 
biofeedback therapy and 
behavioral modification 
Group B) conservative 
therapy (only behavioral 
modification) 
6 and 
12 mos 
Group A 
25/8/8 
Group B 
20/12/12 
6 mos: 
p = 0.01 
12 mos: 
p = 0.009 
Group A 
14/2/4 
Group B 
22/5/10 
6 mos: 
p = 0.02 
12 mos: 
p= 0.3 
Humphreys 
2006 [30] 23 (8/15) (6-15) yrs Severe DES 
Sacral neuromodulation, 
medical therapy 
(4-37 
mos) 
mean 
13.3 
mos 
15/3 
p = 0.001 
18/6 
p < 0.0001 
De Paepe 2000 
[31] 20 (2/18) 
M 4.5 yrs 
F 4.44 yrs DV 
Training program, 
biofeedback, antibiotic 
prophylaxis if UTIs 
recurred, drugs to relieve 
the impaction of 
encopresis 
6-12 
mos 
8/3 
p =  n.a 
8/0 
p = n.a. 
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Table 1 continued. Characteristics and analysis of the included clinical trials 
 
Clinical trials n. (M/F) Mean age (range) Main pathology Treatment 
Follow-
up 
n. of patients 
with 
constipation 
before/after 
n. of patients 
with UTI 
before/after 
Vasconcelos 
2006 [32] 
56 (18/62) 
Group 1 26 
(9/17) 
Group 2 30 
(10/20) 
Group 1 
10.8 ± 1.9 yrs 
Group 2 
10.3 ± 2.6 yrs 
DES 
Group 1) 24 training 
sessions over a 3-month 
period 
Group 2) 16 training 
sessions over 2-month 
period 
12 mos 
Group 1 
11/7 
p = n.s 
Group 2 
11/9 
p = n.s 
Group 1 
8/1 
p = 0.023 
Group 2 
13/3 
p = 0.004 
Yagci 
2005 [33] 168 (16/152) 
7.44 ± 2.24 
(5-14) yrs DV 
Biofeedback, timed 
voiding, high-fiber diets, 
laxatives 
6 mos 
and 2 
yrs 
26/7/9 
p = 0.5 
102/17/13 
p = 0.125 
McKenna 
1999 [34] 41 (8/33) 
7.2 
(5-11) yrs DV 
Pelvic floor muscle 
retraining using interactive 
computer games, timed 
voiding, high-fiber diet 
(3-15 
mos) 
mean 7 
mos 
6 
Improved: 66% 
Cured: 
34% 
p = n.a. 
22/3 
p = n.a. 
Barroso 
2006 [35] 36 (n.a.) 
7 
(3-14) yrs LUTD 
Electrical stimulation 
and/or biofeedback 
training, behavioral 
training, antibiotic 
prophylaxis 
(4-24 
mos) 
mean 
13.8 
mos 
12/3 
p = n.a. 
25/4 
p = n.a. 
Petronijevic 
2007 [26] 9 (girls) 
6.1 
(3-11) yrs DV 
Botulin Toxin type A, 
standard urotherapy, 
education, regular toilet 
visits, dietary and 
hydration changes, 
laxatives 
6 mos 2/1 p = n.a. 
8/2 
p = n.a. 
O’Regan 1985 
[37] 47 (girls) 8.2 ± 2.53 yrs 
Recurrent UTIs, 
constipation Enema regimen 
12±2 
mos 
47/2 
Encopresis 21/1 
p = n.a. 
47/3 
p = n.a. 
Loening-Baucke 
1997 [38] 234 (176/58) 
9 ± 3 
(5-18) yrs CFC, encopresis 
Disimpaction (hypertonic 
phosphate enemas OR 
hyperosmolar milk-of-
molasses enemas), fiber-
rich foods, laxatives, 
education, prophylaxis if 
UTIs recurred 
12 
months 
(mean, 
15 
months
) 
234/112 
p = n.a. 
25/0 
p =n.a. 
Loening-Baucke 
1989 [39] 97 (69/28) 
9.0 
(5-14.5) yrs 
CFC, overflow 
incontinence 
Laxatives, high fiber diet, 
bowel training 12 mos 
97/43 
(F>M) 
n.a. (UTI in 
recovered 3/43, 
UTI in non- 
recovered 11/54; 
p = n.s. 
Khen-Dunlop 
2006 [41] 60 (12/48) 
8 
(5-14) yrs DV 
Pelvic floor training, 
regular voiding 21 mos 25/n.a. 37/6 
Amira 
2013 [42] 72 (girls) 
8 
(7-10) yrs LUTD 
Standard and computer 
game assisted pelvic floor 
muscle retraining 
(6-17 
weeks) 
mean 
11 
weeks 
36/n.a. 
p < 0.002 
70/n.a. 
p < 0.001 
Tugtepe 2015 
[40] 45 (38 female) 8.5 ± 2.2 years 
DV, refractory 
overactive 
bladder 
Biofeedback therapy 3 months 
8/1 
p < 0.05 
20/4 
p < 0.001 
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were different [23, 25, 31, 34-38, 43]. 
      Few studies applied a randomization [26, 27, 29,
32]. In two studies by Vesna et al. [26, 27] divided the
patients into two groups to compare different
treatment regimens for DV; both groups had
significant positive results in terms of amelioration of
UTI recurrence and constipation. In another study,
Kajbafzadeh et al. [29] randomized patients into 2
groups (biofeedback and conservative treatment)
reporting a significant improvement of both
constipation and UTI recurrence. Vasconcelos et al.
[32], who compared two different treatments for DES,
reported in both groups a significant improvement
only in UTIs recurrences, because the prevalence of
constipation had not decreased at follow-up compared
to baseline. 
      Published studies involved a variable number of
patients, from small cohorts of patients to a wide
number (mean 71.4 patients, range 9-234), and often
were only partial [41, 42]. 
      A study of Loening-Baucke [38] is the one with
the largest number of patients. The author observed
that in 234 children with known CFC and encopresis
which treatment of constipation could prevent UTIs in
10% of patients with recurrent UTIs. In a study by the
same author [39], treatment of constipation resulted in
amelioration of the CFC but reported no results in
terms of UTI incidence. Khen-Dunlop et al. [41]
reported the outcome only to resolve UTI recurrences
and not for constipation. A recent study involving 209
children, CFC treatment did not show a significant
(not stated) amelioration of UTIs recurrences [43]. In
particular, this case-control study (105 CFC children
versus 104 controls) showed that the prevalence of
UTI in case and control groups was 13.3% and 6.7%
(p = 0.17), showing a large link between constipation
and UTIs, but the prevalence of UTIs in case group
decreased only to 3.8% after treatment of constipation
[43]. 
      A bias in the clinical trials [26-28, 31, 35, 38] was
the association between antibiotic prophylaxis, used if
UTIs recurred, and constipation treatment. 
DISCUSSION
      UTIs recurrence prevention in children is again a
challenge question whether antimicrobial prophylaxis
is still a matter of debate. It has conducted
investigtions to find optimal approaches to the
assessment and management of UTIs and later
interventions [44, 45]. 
      Studies suggested a link between constipation and
UTI recurrences in children. Guidelines for children
with UTIs considered for investigate and managing of
the bowel dysfunctions. The studies conducted so far
reported a large reduction in UTIs occurrences in
children managed for DES, DV or CFC [26, 28-30,
32, 33, 40]. 
      American Academy of Pediatrics (AAP) published
guidelines for the diagnosis and management of UTIs
in febrile infants and young children younger than 2
years. No mention concerns evaluation and treatment
of the associated constipation [46]. In the same way,
the Italian Society of Pediatric Nephrology reports the
recommendations for diagnosis and treatment of UTIs
#
#
Table 1 continued. Characteristics and analysis of the included clinical trials 
 
Clinical trials n. (M/F) Mean age (range) Main pathology Treatment 
Follow-
up 
n. of patients 
with 
constipation 
before/after 
n. of patients 
with UTI 
before/after 
Sarvari 2017 
[43] 
105 CFC (23.8% 
males) 
104 controls 
(26% males) 
CFC 
4.38 ± 2.38 yrs 
Controls 4.43 ± 
2.44 yrs 
CFC 
Lifestyle changes, child's 
family 
life style modification, 
increased physical 
activity, and 
pharmacotherapy 
3 
months 
CFC 
105/68 -3.8% 
 
CFC = chronic functional constipation, DES = dysfunctional elimination syndrome, DV = dysfunctional voiding (urinary incontinence, 
hesitancy, straining, intermittency, weak stream), LUTD = lower urinary tract dysfunctions, n.a. = not available, n.s. = not significant 
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in children younger than 3 years, but did not mention
evaluation and treatment of constipation in affected
ones [47]. The American Urological Association
(AUA) guidelines recommended a continuous
antimicrobial prophylaxis as management of a child
>1-year-old with VUR, recurrent febrile UTIs, bladder
and bowel dysfunction, or renal cortical anomalies. No
mention regards the constipation in affected children
[48]. The European Urological Association reported
that if symptomsm are suggestive of LUTD (urgency,
incontinence, constipation, or holding manoeuvres),
should do an extensive history and examination. No
mention regarded constipation management in these
children [49].  
      Only NICE clinical guideline
(https://www.nice.org.uk/guidance/qs36) reported that
constipation and DV are risk factors for UTIs and
should as part of history and examination on
confirmed UTI. A systematic review of 27 studies (1
RCT and 26 case studies) on the role of biofeedback
in DES in paediatric patients showed a rate of
improvement from 18% to 100% for constipation and
of 83% in cases of UTI [50]. In children with severe
constipation, a structured bowel management program
decreases unplanned visits to the emergency
department, hospital admissions, and costs for
constipation-related health care for constipation-
related morbidities (abdominal pain 39%, fecal
impaction 17%, urinary retention 2.2%, urinary tract
infections 14%) [51]. 
Limitations 
      Further studies are necessary to show the
effectiveness of constipation treatment regimens in
preventing recurrent UTIs in children. In fact, most
clinical trials, investigating the results of one or more
treatments for constipation in the term of the
resolution or amelioration of UTI recurrence, lacking
in randomization and controlled groups. The published
study results often involved small cohorts of patients
or were only partial. 
CONCLUSION
      In conclusion, constipation seems to be a
predisposing factor for UTIs recurrence in children.
Studies were not homogenous but showed an
improvement in UTIs occurrences in children
managed for CFC or DES. Children referred to a
paediatric nephrologist for UTIs should include an
inquiry on bowel habits and those with a positive
assessment for bowel dysfunction should by a
paediatric gastroenterologist as a multidisciplinary
approach. 
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